Bank of The West Cuts Position in Danaher Co. (DHR)

Bank of The West reduced its position in Danaher Co. (NYSE:DHR) by 5.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 10,823 shares of the conglomerate’s stock after selling 596 shares during the period. Bank of The West’s holdings in Danaher were worth $1,004,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. GQG Partners LLC purchased a new position in Danaher in the second quarter valued at about $101,000. Zions Bancorporation raised its position in Danaher by 118.3% in the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock valued at $106,000 after purchasing an additional 667 shares during the period. Patten Group Inc. raised its position in Danaher by 262.3% in the third quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock valued at $114,000 after purchasing an additional 3,497 shares during the period. First Personal Financial Services raised its position in Danaher by 128.9% in the fourth quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock valued at $114,000 after purchasing an additional 691 shares during the period. Finally, Calton & Associates Inc. purchased a new position in Danaher in the fourth quarter valued at about $114,000. 76.19% of the stock is currently owned by institutional investors and hedge funds.

Several research analysts have commented on the company. Cowen reissued a “buy” rating and issued a $110.00 price objective on shares of Danaher in a research report on Tuesday, January 30th. Credit Suisse Group raised their price objective on Danaher from $99.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Royal Bank of Canada reissued a “hold” rating and issued a $98.00 price objective on shares of Danaher in a research report on Wednesday, January 31st. Morgan Stanley raised their price objective on Danaher from $103.00 to $110.00 and gave the company an “overweight” rating in a research report on Wednesday, January 31st. Finally, Stifel Nicolaus raised their price objective on Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Wednesday, January 31st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $100.13.

In other news, SVP Angela S. Lalor sold 42,988 shares of the firm’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the completion of the sale, the senior vice president now directly owns 82,008 shares in the company, valued at $8,388,598.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Daniel Raskas sold 37,870 shares of the firm’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The disclosure for this sale can be found here. Insiders have sold 274,913 shares of company stock valued at $27,729,293 over the last 90 days. Insiders own 12.20% of the company’s stock.

Shares of Danaher Co. (NYSE DHR) opened at $95.25 on Thursday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.05 and a current ratio of 1.43. The firm has a market capitalization of $67,361.22, a PE ratio of 26.98, a PEG ratio of 2.03 and a beta of 1.04. Danaher Co. has a 52 week low of $78.97 and a 52 week high of $104.82.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.03. The company had revenue of $5.09 billion during the quarter, compared to the consensus estimate of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The company’s revenue was up 10.9% on a year-over-year basis. During the same period last year, the firm earned $1.05 earnings per share. sell-side analysts predict that Danaher Co. will post 4.37 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were paid a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.59%. Danaher’s dividend payout ratio is presently 15.86%.

COPYRIGHT VIOLATION NOTICE: “Bank of The West Cuts Position in Danaher Co. (DHR)” was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international copyright legislation. The correct version of this news story can be viewed at https://sportsperspectives.com/2018/02/08/bank-of-the-west-cuts-position-in-danaher-co-dhr.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply